Trial Profile
Efficacy of pranlukast for nasal symptoms and physical activity in asthma children with moderate/severe allergic rhinitis
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Sep 2013
Price :
$35
*
At a glance
- Drugs Pranlukast (Primary) ; Fexofenadine
- Indications Perennial allergic rhinitis
- Focus Therapeutic Use
- 03 Sep 2013 Planned End Date changed to 30 Jun 2015.
- 03 Sep 2013 New trial record